7 results match your criteria: "William Beaumont Oakland University Medical School[Affiliation]"
Oral D-methionine protects against cisplatin-induced hearing loss in humans: phase 2 randomized clinical trial in India.
Int J Audiol
August 2022
Department of Radiology, University of Michigan, Ann Arbor, MI, USA.
This exploratory Phase 2 clinical trial is the first determining safety and efficacy of oral D-methionine (D-met) in reducing cisplatin-induced ototoxicity. Randomised parallel double-blind placebo-controlled exploratory Phase 2 study. Fifty adult cancer patients received oral D-met or placebo before each cisplatin dose.
View Article and Find Full Text PDFGleason pattern 5 is associated with an increased risk for metastasis following androgen deprivation therapy and radiation: An analysis of RTOG 9202 and 9902.
Radiother Oncol
December 2019
Cedars-Sinai Medical Center, Department of Radiation Oncology, Los Angeles, USA. Electronic address:
Background/purpose: Stratification of Gleason score (GS) into three categories (2-6, 7, and 8-10) may not fully utilize its prognostic discrimination, with Gleason pattern 5 (GP5) previously identified as an independent adverse factor.
Materials/methods: Patients treated on RTOG 9202 (n = 1292) or RTOG 9902 (n = 378) were pooled and assessed for association of GS and GP5 on biochemical failure (BF), local failure (LF), distant metastasis (DM), and overall survival (OS). Fine and Gray's regression and cumulative incidence methods were used for univariate and multivariate analyses.
Quality of life is not compromised with intensification of androgen therapy in recurrent prostate cancer.
Lancet Oncol
October 2018
William Beaumont Oakland University Medical School, Radiation Oncology, Dearborn, MI 48124 USA. Electronic address:
Effect of Standard vs Dose-Escalated Radiation Therapy for Patients With Intermediate-Risk Prostate Cancer: The NRG Oncology RTOG 0126 Randomized Clinical Trial.
JAMA Oncol
June 2018
Cedars-Sinai Medical Center, Los Angeles, California.
Importance: Optimizing radiation therapy techniques for localized prostate cancer can affect patient outcomes. Dose escalation improves biochemical control, but no prior trials were powered to detect overall survival (OS) differences.
Objective: To determine whether radiation dose escalation to 79.
In Regard to Morris et al.
Int J Radiat Oncol Biol Phys
June 2017
Stanford University, Stanford, California.
The authors reply.
Pediatr Crit Care Med
June 2015
Division of Pediatric Critical Care, Department of Pediatrics, University of Missouri, Kansas City/Children's Mercy Hospital, Kansas City, MO Division of Pediatric Critical Care, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX Division of Pediatric Critical Care, Department of Pediatrics, University of Missouri, Kansas City/Children's Mercy Hospital, Kansas City, MO Division of Pediatric Surgery, William Beaumont Oakland University Medical School, Royal Oak, MI Department of Critical Care Services, Children's Medical Center, Dallas, TX Section of Pediatric Critical Care, Department of Pediatrics, Baylor College of Medicine/Texas Children's Hospital, Houston, TX.
Extubation during pediatric extracorporeal membrane oxygenation: a single-center experience.
Pediatr Crit Care Med
November 2014
1Department of Pediatrics, Division of Pediatric Critical Care, University of Texas Southwestern Medical Center, Dallas, TX. 2Department of Pediatrics, Division of Pediatric Critical Care, University of Missouri, Kansas City/Children's Mercy Hospital, Kansas City, MO. 3Division of Pediatric Surgery, William Beaumont Oakland University Medical School, Royal Oak, MI. 4Department of Critical Care Services, Children's Medical Center, Dallas, TX. 5Department of Pediatrics, Section of Pediatric Critical Care, Baylor College of Medicine/Texas Children's Hospital, Houston, TX.
Objectives: Describe aspects of one center's experience extubating infants and children during extracorporeal membrane oxygenation.
Design: Retrospective review of medical records.
Setting: Seventy-one-bed critical care service (PICU and cardiovascular ICU) in a large urban tertiary children's hospital.